Revlimid Prices at US Pharmacies

Our most recent US pharmacy data shows a low of roughly $412.67 for Lenalidomide with a standard discount card. That figure moves with dosage and quantity — check the comparison table for the exact combination you need.

Generic and brand-name pricing for Lenalidomide is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

Even with insurance, patient costs for Revlimid can be substantial. The exact amount you pay—whether a copay or coinsurance—depends entirely on the details of your specific insurance plan, your coverage phase (like deductible or out-of-pocket maximum), and the prescribed dosage. It is advisable to contact your insurance provider or pharmacist to get an estimate of your personal cost. In some instances, it may be beneficial to ask the pharmacy to compare your insurance copay against the price available with other legitimate savings options, such as manufacturer coupons.

Yes, Revlimid is typically covered under Medicare Part D prescription drug plans and Medicare Advantage plans that include drug coverage. However, the patient's cost share can vary widely based on the specific plan's formulary, coverage stage, and benefit design. To determine your exact cost under Medicare, you should consult your plan provider or pharmacist. In some cases, the final price you pay with Medicare coverage may be higher than the cost available through other pharmacy savings programs, so comparing options is recommended.

Yes. Revlimid is the brand-name version of the drug lenalidomide, originally manufactured by Bristol Myers Squibb. The generic form, lenalidomide, is now produced by several pharmaceutical companies, including Apotex, Cipla, and Mylan Pharmaceuticals. The availability of the generic may offer a lower-cost alternative for many patients.